🇺🇸 mixed salts amphetamine in United States
12 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 12
Most-reported reactions
- Headache — 2 reports (16.67%)
- Insomnia — 2 reports (16.67%)
- Amphetamines Negative — 1 report (8.33%)
- Constipation — 1 report (8.33%)
- Drug Effect Variable — 1 report (8.33%)
- Dry Mouth — 1 report (8.33%)
- Educational Problem — 1 report (8.33%)
- Joint Stiffness — 1 report (8.33%)
- Palpitations — 1 report (8.33%)
- Therapeutic Response Unexpected — 1 report (8.33%)
Other Psychiatry / Neurology approved in United States
Frequently asked questions
Is mixed salts amphetamine approved in United States?
mixed salts amphetamine does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for mixed salts amphetamine in United States?
Rush University Medical Center is the originator. The local marketing authorisation holder may differ — check the official source linked above.